Pharmaceutical Executive January 11, 2023
The parameters governing pharma promotional speech in digital and social media have struggled to keep pace with the rapidly evolving healthcare communications landscape. How can FDA play catch-up in advancing an agenda more reflective of industry and patient needs?
There was a time not very long ago when the average patient received the bulk of information about his or her condition while sitting in the doctor’s office. There might have been pharmaceutical company brochures in the waiting area or charts on the wall. The patient may have read about a new treatment recently approved by FDA in a newspaper that appeared at the end of the driveway each morning, or they may have seen a medicine advertised while watching the...
Today's Sponsors
Today's Sponsor